Join the DSECT/DSEN Monthly Seminar Series!
DSECT/DSEN present monthly online seminars for faculty, staff, trainees, decision makers and other stakeholders engaged in drug safety and effectiveness.
This month’s presentation by Dr. Anick Berard will be Available medications used as potential therapeutics for COVID-19: What are the known safety profiles in pregnancy.
Date: May 27, 2021
Time: 3:00-4:00 pm EST
Medications already available to treat other conditions are presently being studied in clinical trials as potential treatments for COVID-19. Given that pregnant women are excluded from these trials, we aimed to investigate their safety when used during pregnancy within a unique population source.
Using the population-based Quebec Pregnancy Cohort, we identified women who delivered a singleton liveborn (1998-2015). Taking potential confounders into account including indications for use, the risk of prematurity, low birth weight (LBW), small for gestational age (SGA), and major congenital malformation (MCM) associated with COVID-19 repurposed drug use during pregnancy were quantified using generalized estimation equations.
The Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program “bridges biosciences, clinical therapeutics, population health, epidemiology, biostatistics, and health services and policy research to better understand choosing, using and losing medications within the context of medication safety and effectiveness.”
For more information, please visit their website: http://www.safeandeffectiverx.com/.